Short-term administration of JAK2 inhibitors reduces splenomegaly in mouse models of β-thalassemia intermedia and major

MeSH terms

• Animals
• Blood Transfusion
• Janus Kinase 2 / antagonists & inhibitors*
• Mice
• Protein Kinase Inhibitors / therapeutic use*
• Splenomegaly / drug therapy*
• Splenomegaly / prevention & control
• beta-Thalassemia / pathology*